Skip to content

Phase 1 Study of PYX-106 in Solid Tumors

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-509686-21-00
Acronym
PYX-106-101
Enrollment
27
Registered
2024-01-11
Start date
2023-07-05
Completion date
2025-05-26
Last updated
2024-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid Tumors

Interventions

None listed

Sponsors

Pyxis Oncology Inc., Pyxis Oncology Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Belgium, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026